Deprecated: Required parameter $cat_id follows optional parameter $type in /www/wwwroot/ebimall.com/systems/hong.php on line 2088

Deprecated: Required parameter $where follows optional parameter $tree_id in /www/wwwroot/ebimall.com/systems/hlb.php on line 3505
Cellagentech/BIBW2992 (Afatinib) | EGFR, Her2 inhibitor/C2929-5/5 mg (powder)188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Cellagentech/BIBW2992 (Afatinib) | EGFR, Her2 inhibitor/C2929-5/5 mg (powder)

ProductDescription

BIBW2992(Afatinib)isanorally-available,aminoquinazoline-acrylamide-basedinhibitorwithIC50potencyforEGFRwt,EGFR(L858R),EGFR(L858R/T790M),andHER2at0.5,0.4,10,and14nM,respectively.[1]Viaitscrotonamidefunctionalgroup,BIBW2992targetstheErbBfamilyinanirreversIBLemanner,providingasustained,selective,andcovalentinhibitionthathasbeenshowntobeeffectivetowarderlotinib-resistanttumors.[2]

Incellularassays,BIBW2992inhibitsphosphorylationofEGFRwildtype(A431),EGFR(NCI-H1975),andHER2(BT474)atEC50sof8,49,and75nM,respectively.[3]

BIBW2992displayspotentgrowthinhibitionofEGFR/HER2expressinglungcancercelllinesH1666,H3255,andNCI1975atIC50valuesof60,0.7,and99nM,respectively.[1]


Technicalinformation:

ChemicalFormula: C24H25ClFN5O3
CAS#: 439081-18-2
MolecularWeight: 485.94
Purity: >98%
Appearance: OffWhite
ChemicalName: (S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
Solubility: Upto100mMinDMSO
Synonyms: BIBW2992,BIBW-2992,Afatinib,Tovok,Tomtovok

ShippingCondition:Theproductisshippedinaglassvialatambienttemperature.
Storagecondition:Forlongershelflife,storesolidpowderat4oCdesiccated,orstoreDMSOsolutionat-20oC.


Reference:

1.Lietal.,BIBW2992,anirreversibleEGFR/HER2inhibitorhighlyeffectiveinpreclinicallungcancermodels.Oncogene,2008,27(34),4702-4711.PubmedID:18408761
2.BoehringerIngelheimbackgrounder(BIBW2992,Afatinib),May,2012.
3.Solcaetal.,Targetbindingpropertiesandcellularactivityofafatinib(BIBW2992),anirreversibleErbBfamilyblocker.J.Pharmacol.Exp.Ther.2012,343(2),342-350.PubmedID:22888144

新闻动态
行业前沿
技术文章
最新产品